| UniProt ID | HVCN1_HUMAN | |
|---|---|---|
| UniProt AC | Q96D96 | |
| Protein Name | Voltage-gated hydrogen channel 1 | |
| Gene Name | HVCN1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 273 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein. Cell membrane Multi-pass membrane protein. Detected mainly at intracellular membranes upon overexpression in HeLa cells (PuMed:20147290), but not in other cell types. |
|
| Protein Description | Mediates the voltage-dependent proton permeability of excitable membranes. Forms a proton-selective channel through which protons may pass in accordance with their electrochemical gradient. Proton efflux, accompanied by membrane depolarization, facilitates acute production of reactive oxygen species in phagocytosis.. | |
| Protein Sequence | MATWDEKAVTRRAKVAPAERMSKFLRHFTVVGDDYHAWNINYKKWENEEEEEEEEQPPPTPVSGEEGRAAAPDVAPAPGPAPRAPLDFRGMLRKLFSSHRFQVIIICLVVLDALLVLAELILDLKIIQPDKNNYAAMVFHYMSITILVFFMMEIIFKLFVFRLEFFHHKFEILDAVVVVVSFILDIVLLFQEHQFEALGLLILLRLWRVARIINGIIISVKTRSERQLLRLKQMNVQLAAKIQHLEFSCSEKEQEIERLNKLLRQHGLLGEVN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Ubiquitination | -MATWDEKAVTRRAK -CCCCCHHHHHHHHC | 45.76 | - | |
| 15 (in isoform 4) | Phosphorylation | - | 8.23 | 27155012 | |
| 23 | Ubiquitination | APAERMSKFLRHFTV CCHHHHHHHHHHCEE | 38.79 | 21890473 | |
| 29 | Phosphorylation | SKFLRHFTVVGDDYH HHHHHHCEEECCCCH | 14.25 | 28857561 | |
| 35 | Phosphorylation | FTVVGDDYHAWNINY CEEECCCCHHHCCCC | 9.74 | 29978859 | |
| 42 | Phosphorylation | YHAWNINYKKWENEE CHHHCCCCCCCCCHH | 15.33 | 22817900 | |
| 43 | Ubiquitination | HAWNINYKKWENEEE HHHCCCCCCCCCHHH | 47.09 | 21890473 | |
| 43 | Ubiquitination | HAWNINYKKWENEEE HHHCCCCCCCCCHHH | 47.09 | 21890473 | |
| 43 (in isoform 1) | Ubiquitination | - | 47.09 | 21890473 | |
| 43 (in isoform 2) | Ubiquitination | - | 47.09 | 21890473 | |
| 43 (in isoform 3) | Ubiquitination | - | 47.09 | 21890473 | |
| 60 | Phosphorylation | EEEQPPPTPVSGEEG HHCCCCCCCCCCCCC | 41.94 | 22617229 | |
| 63 | Phosphorylation | QPPPTPVSGEEGRAA CCCCCCCCCCCCCCC | 41.51 | 30576142 | |
| 90 | Ubiquitination | RAPLDFRGMLRKLFS CCCCCHHHHHHHHHC | 21.33 | 21890473 | |
| 97 | Phosphorylation | GMLRKLFSSHRFQVI HHHHHHHCCCCHHHH | 35.35 | 14702039 | |
| 232 | Ubiquitination | ERQLLRLKQMNVQLA HHHHHHHHHHCHHHH | 40.86 | 29967540 | |
| 252 | Acetylation | LEFSCSEKEQEIERL HHHCCCHHHHHHHHH | 48.69 | 23749302 | |
| 252 | Ubiquitination | LEFSCSEKEQEIERL HHHCCCHHHHHHHHH | 48.69 | 29967540 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HVCN1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HVCN1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MUCL1_HUMAN | MUCL1 | physical | 26186194 | |
| PIGR_HUMAN | PIGR | physical | 26186194 | |
| OXLD1_HUMAN | OXLD1 | physical | 26186194 | |
| CYTN_HUMAN | CST1 | physical | 26186194 | |
| CYTT_HUMAN | CST2 | physical | 26186194 | |
| DOK2_HUMAN | DOK2 | physical | 26186194 | |
| OXLD1_HUMAN | OXLD1 | physical | 28514442 | |
| CYTN_HUMAN | CST1 | physical | 28514442 | |
| DOK2_HUMAN | DOK2 | physical | 28514442 | |
| IGJ_HUMAN | IGJ | physical | 28514442 | |
| PIGR_HUMAN | PIGR | physical | 28514442 | |
| MUCL1_HUMAN | MUCL1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...